Abacavir, Dolutegravir & Lamivudine Tablets

Abacavir, Dolutegravir & Lamivudine Tablets 600,50,300 MG

Indication

Combination of dolutegravir (integrase strand transfer inhibitor [INSTI]), abacavir, and lamivudine (both nucleoside analogue reverse transcriptase inhibitors) is indicated for the treatment of HIV-1 infection in adults and in pediatric patients weighing at least 40 kg.

Pack

30 Tablets Bottle
Category:

Note: Products are not marketed in countries where it is protected by Patent Law